Guilford-based Hyperfine Inc. is now selling its “Swoop” portable magnetic resonance imaging device to medical practitioners in Australia and New Zealand.
The company announced this week that it completed the required registration and notification to make its product available for purchase in the two countries.
Dave Scott, president and CEO of Hyperfine, said the company is excited to enter these new markets.
“Swoop runs on regular wall power and is simple to use,” Scott said. “The portable Hyperfine Swoop MRI system requires no special room build-outs and is available at the patient’s bedside, enabling new care scenarios.”
The company aims to expand globally, and in recent months has expanded into markets in Canada, the United Kingdom and Pakistan.
Swoop, which is approved by the U.S. Food and Drug Administration, can be wheeled to a patient’s bedside and plugs into a standard electrical wall outlet. It is controlled by a tablet and provides imaging quickly, allowing physicians to diagnose and treat patients anywhere, including remote and rural areas.
According to Hyperfine, pilot research units have been ordered in Australia already, and the company expects this will bolster its commercial entry into the market.
Quantum HealthCare, a medical equipment distributor which is part of Paragon Care Limited, will be Hyperfine’s distributor in Australia and New Zealand.
Quantum HealthCare General Manager Tiffany Chiew said in an announcement, “We are optimistic about the acceptance and growth of Hyperfine’s innovative technology in the region.”
Alfred Health in Melbourne has been using the Swoop system for research purposes since 2021.
Meng Law, director of radiology for Alfred Health, said the technology has positively impacted the diagnosis and evaluation of patients in intensive care.
“Reducing the staff and time needed in transporting very ill patients to the medical imaging department improves outcomes for patients,” Law said.
Contact Michelle Tuccitto Sullo at msullo@newhavenbiz.com.
